BioSpace News Archive

Press Releases

Avacta announces first patient treated in Phase 1 FOCUS-01 trial of FAP-Exd (AVA6103) - a sustained-release pre|CISION® exatecan peptide drug conjugate

March 31, 2026
·
5 min read
Press Releases

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

March 31, 2026
·
3 min read
Press Releases

CancerVax Reports Successful Initial Mouse Study with Breakthrough Results

March 31, 2026
·
6 min read
Press Releases

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

March 31, 2026
·
6 min read
Press Releases

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis

March 31, 2026
·
9 min read
Press Releases

Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis

March 31, 2026
·
3 min read
Press Releases

Semarion Secures $3.8 Million to Scale Next-Generation Cell Assay Technology and Accelerate Pharma Adoption

March 31, 2026
·
3 min read
Press Releases

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026

March 31, 2026
·
4 min read
Press Releases

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

March 31, 2026
·
17 min read
Press Releases

BioInvent International AB Publishes Annual Report 2025

March 31, 2026
·
5 min read